K. J. M. Aung - Concepedia

Author

K. J. M. Aung

Instituut voor Tropische Geneeskunde

Also Known As

A. Islam, K J Aung, K J M Aung, K. J. M. Aung, Kimberly Aung, Kya J. M. Aung, Kya J.M. Aung, Kya Jai Maug Aung

Publications

Citations

H-Index

Concepts

All Affiliations

Instituut voor Tropische Geneeskunde Damien Foundation International Union Against Tuberculosis and Lung Disease University of Antwerp University of Zurich

About

K. J. M. Aung is an author at Instituut voor Tropische Geneeskunde specializing in antimicrobial resistance, molecular diagnostics, and bioinformatics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	240
2	Medicine	1	1	240
3	Pathology	1	1	240
4	Pharmacology	1	1	240
5	Clinical Microbiology	1	1	240

K. J. M. Aung

Publications

947

Citations

H-Index

Page 1

	Year	Citations
Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients K. J. M. Aung, Armand Van Deun, Mihir Ranjan Sarker, The International Journal of Tuberculosis and Lung Disease	2014	316
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard Armand Van Deun, K. J. M. Aung, Valentin Bola, Journal of Clinical Microbiology Tuberculosis PreventionInsufficient SpecificityPathologyPharmacotherapyAntibiotic Resistance	2013	240
Disputed <I>rpo</I>B mutations can frequently cause important rifampicin resistance among new tuberculosis patients Armand Van Deun, K. J. M. Aung, Pim de Rijk, The International Journal of Tuberculosis and Lung Disease	2015	97
Specific<i>gyrA</i>gene mutations predict poor treatment outcome in MDR-TB Leen Rigouts, Nele Coeck, Mourad Gumusboga, Journal of Antimicrobial Chemotherapy	2015	95
Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB. A Hamid Salim, K. J. M. Aung, M A Hossain, PubMed	2006	53
Scanty AFB smears: what's in a name? Armand Van Deun, A Hamid Salim, E Cooreman, PubMed	2004	30
Gatifloxacin is superior to levofloxacin and moxifloxacin in shorter treatment regimens for multidrug-resistant TB Armand Van Deun, Tom Decroo, Christopher Kuaban, The International Journal of Tuberculosis and Lung Disease	2019	30
Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens. Armand Van Deun, K. J. M. Aung, Subhadeep Chowdhury, PubMed	1999	26
Drug resistance monitoring: combined rates may be the best indicator of programme performance. Armand Van Deun, AFM Salim, Paul Daru, PubMed	2004	21
Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen Pauline Lempens, Tom Decroo, K. J. M. Aung, International Journal of Infectious Diseases	2020	15

Page 1